Of these 50 semaglutide-treated patients that developed anti-semaglutide antibodies, 28 patients (1.6% of the overall population) developed antibodies cross-reacting with native GLP-1.The in vitro neutralizing activity of the antibodies is uncertain at this time
Common side effects (may affect up to 1 in 10 people): * Pain, redness, or swelling at the injection site * Nausea * Headache Uncommon side effects (may affect up to 1 in 100 people): * Diarrhea * Dizziness * Allergic reactions such as skin rash, itching, or hives Rare side effects (may affect up to 1 in 1,000 people): * Severe allergic reaction (anaphylaxis) with symptoms like difficulty breathing, swelling of the face or throat, and a drop in blood pressure
The quality of your peptide shouldn't be one of them
-Melanocyte-Stimulating Hormone Agonists : This fascinating innovation stimulates melanocyte activity, potentially increasing pigment production in greying follicles
We have reviewed and provided updates on present-day metal chelating agents commonly used in clinical settings
Its a catastrophic, yet completely avoidable, outcome
